These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23632880)

  • 1. Choline PET/CT for imaging prostate cancer: an update.
    Kitajima K; Murphy RC; Nathan MA
    Ann Nucl Med; 2013 Aug; 27(7):581-91. PubMed ID: 23632880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
    Krause BJ; Souvatzoglou M; Treiber U
    Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline PET/CT for prostate cancer: main clinical applications.
    Fuccio C; Rubello D; Castellucci P; Marzola MC; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e50-6. PubMed ID: 20800404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
    von Eyben FE; Kairemo K
    Nucl Med Commun; 2014 Mar; 35(3):221-30. PubMed ID: 24240194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
    Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
    J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Zengerling F; Schrader AJ; Schrader M; Jentzmik F
    Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
    BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
    Calabria F; Chiaravalloti A; Tavolozza M; Ragano-Caracciolo C; Schillaci O
    Nucl Med Commun; 2013 Aug; 34(8):733-40. PubMed ID: 23680652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
    Kwee SA; Coel MN; Ly BH; Lim J
    Ann Nucl Med; 2009 Aug; 23(6):541-8. PubMed ID: 19529978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases.
    Chondrogiannis S; Marzola MC; Grassetto G; Rampin L; Massaro A; Colletti PM; Rubello D
    Clin Nucl Med; 2015 Jun; 40(6):e308-12. PubMed ID: 25742236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
    Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
    Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
    Fanti S; Minozzi S; Castellucci P; Balduzzi S; Herrmann K; Krause BJ; Oyen W; Chiti A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):55-69. PubMed ID: 26450693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis.
    Evangelista L; Zattoni F; Guttilla A; Saladini G; Zattoni F; Colletti PM; Rubello D
    Clin Nucl Med; 2013 May; 38(5):305-14. PubMed ID: 23486334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
    Schwarzenböck SM; Kurth J; Gocke Ch; Kuhnt T; Hildebrandt G; Krause BJ
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1():S28-35. PubMed ID: 23576101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective head-to-head comparison of
    Eiber M; Rauscher I; Souvatzoglou M; Maurer T; Schwaiger M; Holzapfel K; Beer AJ
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2179-2188. PubMed ID: 28803358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.